Company
United StatesPublic company, NYSE: DLXDeluxe Corporation (NYSE: DLX), Monroe, WA – FDA Inspections
Inspection records and compliance data for Deluxe Corporation in Monroe, Washington. 2 FDA inspections on record, last inspected December 12, 2017. Publicly traded as NYSE: DLX.
Company Profile
This profile covers Deluxe Corporation based in Monroe, Washington, United States.
FDA Inspection History
- FDA inspections
- 2
- OAI
- 0
- VAI
- 0
- NAI
- 2
- Form 483s
- 0
- Warning letters
- 0
First inspected April 25, 2012. Last inspected December 12, 2017.
FDA inspections (2)
| Date | Result | FDA center(s) | Insp. # |
|---|---|---|---|
| December 12, 2017 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 1044982 |
| April 25, 2012 | NAI | Foods & Cosmetics · Foodborne Biological Hazards | 778447 |
FDA documents
No Form 483s, Warning Letters or EIRs on record.
Related Companies (10)
Companies with similar regulatory profiles, compliance history, and operations.
Company Information
Name
Deluxe Corporation
Stock ticker
DLX
Exchange
NYSE
Share price
$27.87
Market cap
$1.3B
Price as of
November 6, 2026
FEI Number
3005302988
Address
14640 172nd Dr Se, Monroe, Washington 98272, United States
Country
United States
ID: b21d833c-254c-4acb-a1d6-fe3535951a92